Patents by Inventor Rolf Loeffler

Rolf Loeffler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ORGANIC COMPOUNDS
    Publication number: 20220273574
    Abstract: A pharmaceutical composition comprises octreotide acetate microparticles of linear poly (lactide-co-glycolide) polymer wherein the polymer contains less than 1% silicone oil or heptane.
    Type: Application
    Filed: May 19, 2022
    Publication date: September 1, 2022
    Inventors: Holger PETERSEN, Olivier Jean LAMBERT, Rolf LÖFFLER, Michael AUSBORN, Jean-Daniel BONNY
  • ORGANIC COMPOUNDS
    Publication number: 20200009056
    Abstract: A pharmaceutical composition comprises octreotide acetate microparticles of linear poly (lactide-co-glycolide) polymer wherein the polymer contains less than 1% silicone oil or heptane.
    Type: Application
    Filed: September 19, 2019
    Publication date: January 9, 2020
    Inventors: Holger Petersen, Olivier Jean Lambert, Rolf Löffler, Michael Ausborn, Jean-Daniel Bonny
  • Organic Compounds
    Publication number: 20170281548
    Abstract: A pharmaceutical composition comprises octreotide acetate microparticles of linear poly (lactide-co-glycolide) polymer wherein the polymer contains less than 1% silicone oil or heptane.
    Type: Application
    Filed: June 20, 2017
    Publication date: October 5, 2017
    Inventors: Holger PETERSEN, Olivier Jean LAMBERT, Rolf LÖFFLER, Michael AUSBORN, Jean-Daniel BONNY
  • Organic compounds
    Patent number: 8815293
    Abstract: A depot formulation comprising iloperidone and a biodegradable, biocompatible polymer. Preferably, the polymer is a star polymer.
    Type: Grant
    Filed: May 20, 2010
    Date of Patent: August 26, 2014
    Assignee: Novartis AG
    Inventors: Markus Ahlheim, Rolf Loeffler
  • BISPHOSPHONATE PRODUCT IN A CYCLOOLEFINIC POLYMER CONTAINER
    Publication number: 20120027818
    Abstract: A pharmaceutical product comprises a container containing a bisphosphonate solution, in which at least the internal surface of the container comprises a plastic material and in which the container is heat sterilisable, and which is in the form of an infusion solution preconcentrate for administration of the bisphosphonate to a patient in need of bisphosphonate treatment.
    Type: Application
    Filed: September 23, 2011
    Publication date: February 2, 2012
    Inventors: Alexandra Glausch, Rolf Loeffler, Juergen Sigg
  • Pharmaceutical products comprising bisphosphonates
    Patent number: 7932241
    Abstract: A pharmaceutical product comprises a container containing a bisphosphonate solution, in which at least the internal surface of the container comprises a plastic material and in which the container is heat sterilisable, and which is in the form of a ready to use infusion solution, for administration of the bisphosphonate to a patient in need of bisphosphonate treatment.
    Type: Grant
    Filed: September 17, 2004
    Date of Patent: April 26, 2011
    Assignee: Novartis AG
    Inventors: Alexandra Glausch, Rolf Löffler, Juergen Sigg
  • ORGANIC COMPOUNDS
    Publication number: 20100233217
    Abstract: A depot formulation comprising iloperidone and a biodegradable, biocompatible polymer. Preferably, the polymer is a star polymer.
    Type: Application
    Filed: May 20, 2010
    Publication date: September 16, 2010
    Applicant: NOVARTIS AG
    Inventors: Markus Ahlh im, Rolf Loeffler
  • Organic compounds
    Patent number: 7767230
    Abstract: A depot formulation comprising iloperidone and a biodegradable, biocompatible polymer. Preferably, the polymer is a star polymer.
    Type: Grant
    Filed: October 30, 2002
    Date of Patent: August 3, 2010
    Assignee: Novartis AG
    Inventors: Markus Ahlheim, Rolf Loeffler
  • PHARMACEUTICAL COMPOSITIONS COMPRISING BISPHOSPONATES
    Publication number: 20100047306
    Abstract: The present invention relates to depot formulations comprising a poorly water soluble salt of a bisphosphonate forming together with one or more biocompatible polymers. The depot formulation may be in the form of microparticles or implants. The depot formulations are useful for the treatment and prevention of proliferative diseases including cancer.
    Type: Application
    Filed: October 3, 2007
    Publication date: February 25, 2010
    Applicant: NOVARTIS AG
    Inventors: Rolf Loeffler, Holger Petersen, Juergen Sigg, Gesine Winzenburg
  • PHARMACEUTICAL PRODUCTS COMPRISING BISPHOSPHONATES
    Publication number: 20080254089
    Abstract: A pharmaceutical product comprises a container containing a bisphosphonate solution, in which at least the internal surface of the container comprises a plastic material and in which the container is heat sterilisable, and which is in the form of an infusion solution preconcentrate for administration of the bisphosphonate to a patient in need of bisphosphonate treatment.
    Type: Application
    Filed: June 18, 2008
    Publication date: October 16, 2008
    Inventors: Alexandra Glausch, Rolf Loeffler, Juergen Sigg
  • Organic compounds
    Publication number: 20070122485
    Abstract: A pharmaceutical composition comprises octreotide acetate microparticles of linear poly (lactide-co-glycolide) polymer wherein the polymer contains less than 1% silicone oil or heptane.
    Type: Application
    Filed: January 8, 2007
    Publication date: May 31, 2007
    Inventors: Holger Petersen, Olivier Lambert, Rolf Loeffler, Michael Ausborn, Jean-Daniel Bonny
  • Pharmaceutical products comprising bisphosphonated
    Publication number: 20050119230
    Abstract: A pharmaceutical product comprises a container containing a bisphosphonate solution, in which at least the internal surface of the container comprises a plastic material and in which the container is heat sterilisable, and which is in the form of an infusion solution preconcentrate for administration of the bisphosphonate to a patient in need of bisphosphonate treatment.
    Type: Application
    Filed: September 15, 2004
    Publication date: June 2, 2005
    Inventors: Alexandra Glausch, Rolf Loeffler, Juergen Sigg
  • Organic compounds
    Publication number: 20040097419
    Abstract: A pharmaceutical composition comprises octreotide acetate microparticles of linear poly (lactide-co-glycolide) polymer wherein the polymer contains less than 1% silicone oil or heptane.
    Type: Application
    Filed: December 6, 2002
    Publication date: May 20, 2004
    Inventors: Holger Petersen, Olivier Lambert, Rolf Loeffler, Michael Ausborn, Jean-Daniel Bonny
  • Organic compounds
    Publication number: 20030091645
    Abstract: A depot formulation comprising iloperidone and a biodegradable, biocompatible polymer. Preferably, the polymer is a star polymer.
    Type: Application
    Filed: October 30, 2002
    Publication date: May 15, 2003
    Inventors: Markus Ahlheim, Rolf Loeffler